Bluejay Diagnostics, Inc. (BJDX) earnings
BJDX earnings moved a median of +2.00% by the close. Quarterly and annual BJDX reports and results, each read against the price at its own news timestamp. Back to the BJDX overview →
16 measured BJDX earnings events.
Where these BJDX earnings landedvs 16 measured BJDX earnings reactions
| Middle 50% of BJDX earnings reactions | -3.12% to +5.71% |
|---|---|
| Median reaction (to close) | +2.00% |
| Measured reactions | 16 |
Point-in-time · zero look-ahead
Half of the 16 BJDX earnings events with a measured close landed between -3.12% and +5.71%; 63% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ IL-6 Toward Regulatory Submission and Commercialization | Press release | +2.50% | +6.00% | |
| Form 10-Q Bluejay Diagnostics, For: Jun 30 | SEC filing · Form 10-Q | +2.50% | +6.00% | |
| Bluejay Diagnostics Provides First Quarter 2026 Corporate Update | Press release | +0.00% | -4.97% | |
| Form 10-Q Bluejay Diagnostics, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -4.97% | |
| Form 10-K Bluejay Diagnostics, For: Dec 31 | SEC filing · Form 10-K | +0.54% | +1.08% | |
| Form 10-Q Bluejay Diagnostics, For: Sep 30 | SEC filing · Form 10-Q | +1.11% | +0.64% | |
| Form 10-Q Bluejay Diagnostics, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -4.11% | |
| Form 10-Q Bluejay Diagnostics, For: Mar 31 | SEC filing · Form 10-Q | +1.15% | -1.72% | |
| Form 10-K/A Bluejay Diagnostics, For: Dec 31 | SEC filing · Form 10-K | +3.85% | +4.95% | |
| Form 10-K Bluejay Diagnostics, For: Dec 31 | SEC filing · Form 10-K | +0.54% | -2.95% | |
| Form 10-Q Bluejay Diagnostics, For: Sep 30 | SEC filing · Form 10-Q | +4.51% | +13.75% | |
| Form 10-Q Bluejay Diagnostics, For: Jun 30 | SEC filing · Form 10-Q | +4.32% | +4.79% | |
| Form 10-Q Bluejay Diagnostics, For: Mar 31 | SEC filing · Form 10-Q | -6.21% | +2.92% | |
| Form 10-K Bluejay Diagnostics, For: Dec 31 | SEC filing · Form 10-K | -1.63% | -3.63% | |
| Bluejay Diagnostics, Inc. Reports Third Quarter 2023 Financial Results | Press release | +0.00% | +5.71% | |
| Form 10-Q Bluejay Diagnostics, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +5.71% |
Keep exploring
More BJDX: analyst actions → · SEC filings → · BJDX overview →